TGFB1 and glioblastoma: Increased c-MET and TGF-β pathway activity may promote tumor progression in glioblastoma via invasion, migration, angiogenesis, cell survival, SC maintenance, and immune evasion13,23–28, however, their potential interactions may not have been sufficiently studied.